Outcome of High-Risk and Refractory AML/MDS Patients Receiving a FLAMSA Sequential Chemotherapy Regimen Followed by Reduced-Intensity Conditioning (RIC) and Allogeneic Hematopoeitic Stem Cell Transplantation (allo-HSCT)Marie Y. Detrait, Mauricette Michallet, Fiorenza Barraco et al.|Blood|2011Cited by 5
Highly Significant Impact of HLA-DRB3 and HLA-DRB4 Matching on Different Unrelated Allo-HSCT Outcomes: New Perspectives in the Unrelated Donor SelectionMarie Y. Detrait, Mauricette Michallet, Valérie Dubois et al.|Blood|2011Cited by 1
Is the Use of 9/10 HLA Unrelated Donors Still Acceptable in Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies? Comparison with Transplants From 10/10 HLA Unrelated Donors and SiblingsMauricette Michallet, Franck E. Nicolini, Mohamad Sobh et al.|Blood|2011Cited by 0
Double Cord Blood Units Allogeneic Transplantation for Hematological Malignancies: Study of the “3 Partners” Matching Variables on Transplant OutcomesMauricette Michallet, Valérie Dubois, Mohamad Sobh et al.|Blood|2011Cited by 0
The Impact of Anti-HLA Antibodies on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes After Reduced-Intensity Conditioning RegimensMarie Y. Detrait, Mauricette Michallet, Valérie Dubois et al.|Blood|2011Cited by 0